Peter H. Slugg

450 total citations
19 papers, 335 citations indexed

About

Peter H. Slugg is a scholar working on Pharmacology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter H. Slugg has authored 19 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Pharmacology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter H. Slugg's work include Pharmacogenetics and Drug Metabolism (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Platelet Disorders and Treatments (2 papers). Peter H. Slugg is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Platelet Disorders and Treatments (2 papers). Peter H. Slugg collaborates with scholars based in United States, Germany and Poland. Peter H. Slugg's co-authors include William J. Jusko, Neville F. Ford, Amarnath Sharma, Thomas G. Wells, John J. Stewart, Maria Rosaria Marino, J Necciari, Abdullah Şakarcan, William Smith and John T. Wilson and has published in prestigious journals such as JAMA, Neurosurgery and Pharmaceutical Research.

In The Last Decade

Peter H. Slugg

17 papers receiving 309 citations

Peers

Countries citing papers authored by Peter H. Slugg

Since Specialization

Citations

This map shows the geographic impact of Peter H. Slugg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Slugg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Slugg more than expected).

Fields of papers citing papers by Peter H. Slugg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter H. Slugg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Slugg. The network helps show where Peter H. Slugg may publish in the future.

Co-authorship network of co-authors of Peter H. Slugg

This figure shows the co-authorship network connecting the top 25 collaborators of Peter H. Slugg. A scholar is included among the top collaborators of Peter H. Slugg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter H. Slugg. Peter H. Slugg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Comparitive Vancomycin Kinetics in Intensive Care Unit Patients with Acute Renal Failure: Intermittent Hemodialysis versus Continuous Hemofiltration Hemodialysis 2015 ·Contributions to nephrology ·Peter H. Slugg, Marcus T. Haug, (unknown), (unknown)	0
2	The Pharmacokinetics of Irbesartan in Hypertensive Children and Adolescents 2001 ·The Journal of Clinical Pharmacology ·Abdullah Şakarcan, (unknown), John T. Wilson, John J. Stewart, Kim G. Adcock, Thomas G. Wells, Nimish N. Vachharajani, (unknown), Peter H. Slugg, Neville F. Ford, Maria Rosaria Marino	52
3	Cirrhosis Does Not Affect the Pharmacokinetics and Pharmacodynamics of Clopidogrel 2000 ·The Journal of Clinical Pharmacology ·Peter H. Slugg, (unknown), William Smith, (unknown), (unknown), J Necciari	29
4	Estimation of Oral Bioavailability of a Long Half-Life Drug in Healthy Subjects 1998 ·Pharmaceutical Research ·(unknown), Peter H. Slugg, (unknown), William J. Jusko	15
5	Clinical Pharmacokinetics and Pharmacodynamics of a New Squalene Synthase Inhibitor, BMS‐188494, in Healthy Volunteers 1998 ·The Journal of Clinical Pharmacology ·Amarnath Sharma, Peter H. Slugg, (unknown), William J. Jusko	27
6	A Pharmacokinetic—Pharmacodynamic Model of d‐Sotalol Q‐Tc Prolongation During Intravenous Administration to Healthy Subjects 1997 ·The Journal of Clinical Pharmacology ·Daniel E. Salazar, (unknown), (unknown), James R. Seibold, Daniel M. Shindler, Peter H. Slugg	15
7	The pharmacokinetics of pravastatin in patients on chronic hemodialysis 1997 ·European Journal of Clinical Pharmacology ·T. W. B. Gehr, Domenic A. Sica, Peter H. Slugg, (unknown), (unknown), Neville F. Ford	22
8	The pharmacokinetics (PK) and pharmacodynamics (PD) of d-sotalol (DS) in subjects with renal failure (RF). 1996 ·Clinical Pharmacology & Therapeutics ·Domenic Sica, T. W. B. Gehr, (unknown), Peter H. Slugg	1
9	Ranitidine Pharmacokinetics and Adverse Central Nervous System Reactions 1992 ·Archives of Internal Medicine ·Peter H. Slugg	29
10	Speaking and Writing for the Physician 1987 ·Therapeutic Drug Monitoring ·Peter H. Slugg	1
11	The Aging Process: Therapeutic Implications 1985 ·Cleveland Clinic Journal of Medicine ·Z. N. Zakov, Peter H. Slugg	2
12	Necrolytic migratory erythema-like dermatitis with malabsorption 1985 ·Cleveland Clinic Journal of Medicine ·(unknown), (unknown), Peter H. Slugg, Wilma F. Bergfeld, (unknown)	5
13	Theophylline and its interactions 1985 ·Cleveland Clinic Journal of Medicine ·Donald G. Vidt, A. W. Bakst, Peter H. Slugg, C. E. Pippenger	1
14	Handbook of Clinical Pharmacokinetics 1984 ·Therapeutic Drug Monitoring ·Peter H. Slugg	38
15	Pharmacokinetic Basis for Drug Treatment 1984 ·Therapeutic Drug Monitoring ·Peter H. Slugg	82
16	Case Report: Disorder of Excessive Somnolence Due to Central Nervous System Lymphoma 1983 ·Neurosurgery ·Ronald P. Lesser, (unknown), Dudley S. Dinner, Maurice R. Hanson, John R. Little, Peter H. Slugg	2
17	Alport's syndrome (hereditary nephritis): Report of six cases and review of the literature 1970 ·Cleveland Clinic Journal of Medicine ·Peter H. Slugg, Daniel C. Humphrey	0
18	Complications of methysergide therapy: retroperitoneal fibrosis, mitral regurgitation, edema, and hemolytic anemia 1970 ·JAMA ·Peter H. Slugg	7
19	Complications of Methysergide Therapy 1970 ·JAMA ·Peter H. Slugg	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact